New polymerization technology may one day take the pain out of injections and blood draws. A team of researchers at the University of North Carolina and Laser Zentrum Hannover have recently used two-photon polymerization to create hollow needles so fine patients wouldn’t feel them piercing their skin. Clustered together on a patch, these microneedles can deliver drugs or draw blood efficiently as standard hypodermic needles. These findings are reported in the International Journal of Applied Ceramic Technology.
Developing a way to deliver drugs intravenously with minimal pain and trauma, by someone without medical expertise, has long been a mission of biomedical engineers. Until recently, their most promising product had been stainless steel and titanium microneedles. These metal microneedles, though, are prone to break on impact with skin.
Researchers led by Roger Narayan, MD, PhD, of the University of North Carolina , used two-photon polymerization of organically modified ceramic (Ormocer®) hybrid materials to create microneedles resistant to breakage. Another benefit of the hybrid needles is that they can be made in a wider range of sizes than those made with conventional microfabrication techniques.
The first patients Narayan imagines will benefit from his technique are those who require frequent injections or blood monitoring.
Source: Blackwell Publishing Ltd.
Related stories:
Microneedles Could Replace Syringe
The common needle phobia and painful injections could soon be a thing of the past, thanks to a revolutionary new drug-delivery technique developed by a team at the Georgia Institute of Technology, US. The long-practiced method of drug administration has up to now involved the use of hypodermic needles but they have many drawbacks, including pain, risk of infection, and the need for trained staff to perform the injection.
Microneedles enhance drug administration through skin
In what is believed to be the first peer-reviewed study of its kind involving human subjects, researchers at the University of Kentucky College of Pharmacy and the Georgia Institute of Technology have demonstrated that patches coated on one side with microscopic needles can facilitate transdermal delivery of clinically-relevant doses of a drug that normally cannot pass through the skin.
ACP recommends routine HIV screening for all patients
On World AIDS Day, the American College of Physicians (ACP) is giving doctors a call-to-action to routinely encourage HIV screening to all of their patients older than 13 years. This new practice guideline appears on the
Annals of Internal Medicine Web site at
www.annals.org.
Girl's immune deficiency nearly cured
Yet another intravenous needle sticks Jayla Turner's tiny arm, and the only consolation for hearing the baby's cries is the knowledge that soon, she will be free of such assaults.
Battling bacteria in the blood: Researchers tackle deadly infections
It's a leading cause of death, but no one knows for sure how and why it happens. It's a major source of health care costs, adding days or weeks to the hospital stays and lost work time of millions of people. But no one fully understands how best to fight it.
Newly tested compound makes Gram negative bacteria less virulent
(PhysOrg.com) -- A newly tested compound appears to inhibit certain mechanisms that make Gram-negative bacteria virulent disease agents.
Nano vaccine for hepatitis B shows promise for third world
Chronic hepatitis B infects 400 million people worldwide, many of them children. Even with three effective vaccines available, hepatitis B remains a stubborn, unrelenting health problem, especially in Africa and other developing areas. The disease and its complications cause an estimated 1 million deaths globally each year.
Some patients may not need insulin for long-term control of type 2 diabetes
Some patients with type 2 diabetes can control their disease for years yet avoid insulin injections by using multiple classes of oral diabetic medications, a new study found. The results were presented Sunday, June 15, at The Endocrine Society's 90th Annual Meeting in San Francisco.